← Open Payments lookup

MEGAN SLOAN: Open Payments

NPI 1639425499 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$656 in 31 payments from 10 companies in 2025. Trend: 2023 $208 · 2024 $780 · 2025 $656

Food & beverage: $656
CompanyPaymentsAmount
Axsome Therapeutics, Inc.11$257
Otsuka America Pharmaceutical, Inc.5$95
Neurocrine BioSciences, Inc.4$79
Lundbeck LLC3$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Takeda Pharmaceuticals U.S.A., Inc.2$29
Vanda Pharmaceuticals Inc.1$24
Teva Pharmaceuticals USA, Inc.1$23
ABBVIE INC.1$21
Collegium Pharmaceutical, Inc.1$17

Products named: Auvelity, REXULTI, INGREZZA, CAPLYTA, TRINTELLIX, FANAPT, AUSTEDO XR, VRAYLAR.

Industry payments across WI — which companies pay providers there.